康龙化成（北京）新药技术股份有限公司（3759）将于2025年12月18日下午2时30分在北京市经济技术开发区泰河路6号召开2025年第一次临时股东大会。议程包括补选第三届董事会独立非执行董事，以及修订《关联╱关联交易管理制度》《对外担保管理制度》《独立非执行董事工作制度》《对外投资管理制度》《募集资金专项存储及使用管理制度》《累积投票制实施细则》和《股东提名个别人士为董事之程序》。另将就修订《公司章程》《股东大会议事规则》及《董事会议事规则》作特别决议。投票结果将在香港联合交易所有限公司网站(www.hkexnews.hk)及公司网站(www.pharmaron.cn)发布。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.